Work

O-011 Low-dose IL-2 Administration Expands Human Regulatory T Cells in Patients with UC and Humanized Mice and Protects Against Experimental Colitis.

Year: 2017

Type: conference-abstract

Source: Inflammatory Bowel Diseases

DOI: 10.1097/01.mib.0000512521.84210.0b

Authors: Jeremy A. Goettel, Daniel Kotlarz, David W. Illig, James B. Canavan, Jessica R. Allegretti, Matthew J. Hamilton, Ryan Kelly, Alexandra Griffith, Madeline Carellas, Anastasia Nelina, Athos Bousvaros, Joshua R. Korzenik, Scott B. Snapper

Institutions: Boston Children's Hospital, Harvard University, Ludwig-Maximilians-Universität München, Brigham and Women's Hospital

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2584802312

Cites:

Cited by: 3

Related to: 10